Research for change: Using implementation research to strengthen HIV care and treatment scale-up in resource-limited settings

Journal of Infectious Diseases

Volumn 196, Issue SUPPL. 3, 2007, Pages

  Hirschhorn, Lisa R ^a,b   Ojikutu, Bisola ^a,c   Rodriguez, William ^a,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b JSI RESEARCH AND TRAINING INSTITUTE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Clinton Foundation HIV/AIDS Initiative   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CLINICAL RESEARCH; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; HEALTH CARE; HEALTH CARE MANAGEMENT; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; MEDICAL RESEARCH; PRIORITY JOURNAL; TOTAL QUALITY MANAGEMENT; VIRUS TRANSMISSION; ECONOMICS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; METHODOLOGY; REVIEW; VIROLOGY;

DELIVERY OF HEALTH CARE; HEALTH PLAN IMPLEMENTATION; HIV INFECTIONS; HUMANS;

EID: 39549093127     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/521120     Document Type: Conference Paper

References (50)

1. Coetzee D, Hildebrand K, Boulle A, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004; 18:887-95.
2. Koenig S, Leandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: the rural Haiti experience. AIDS 2004; 18:S21-5.
3. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet 2006; 367:1335-42.
4. Chen RY, Westfall AO, Hardin JM, et al. Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings. J Acquir Immune Defic Syndr 2007; 44:525-30.
5. Gilks CF, Crowley S, Ekpini R, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-10.
6. + T-cell counting of HIV-infected subjects in resource-poor settings. J Acquir Immune Defic Syndr 2007; 45:257-61.
7. Laurent C, Kouanfack C, Koulla-Shiro S, et al. Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial. Lancet 2004; 364:29-34.
8. Hill A, Ruxrungtham K, Hanvanich M, et al. Systematic review of clinical trials evaluating low doses of stavudine as part of antiretroviral treatment. Expert Opin Pharmacother 2007; 8:679-88.
9. Perez F, Zvandaziva C, Engelsmann B, Dabis F. Acceptability of routine HIV testing ("opt-out") in antenatal services in two rural districts of Zimbabwe. J Acquir Immune Defic Syndr 2006; 41:514-20.
10. Goldie SJ, Yazdanpanah Y, Losina E, et al. Cost-effectiveness of HIV treatment in resource-poor settings - the case of Côte d'Ivoire. N Engl J Med 2006; 355:1141-53.
11. Badri M, Cleary S, Maartens G, et al. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther 2006; 11:63-72.
12. Huddart J, Furth R, Lyons JV. The Zambia HIV/AIDSWorkforce Study: preparing for scale-up. Available at: http://www.initiativesinc.com/resources/ publications/docs/ZambiaAIDSWorkforceStudy.pdf. Accessed 16 April 2007.
13. Robbins GK, De Gruttola V, Shafer RW, et al. Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection. N Engl J Med 2003; 349:2293-303.
14. Lallemant M, Jourdain G, Le Coeur S, et al. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand. N Engl J Med 2004; 351:217-28.
15. Thior I, Lockman S, Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 2006; 296:794-805.
16. Sanders D, Haines A. Implementation research is needed to achieve international health goals. PLoS Med 2006; 3:e186.
17. Radilla-Chávez P, Laniado-Laborin R. Results of directly observed treatment for tuberculosis in Ensenada, Mexico: not all DOTS programs are created equally. Int J Tuberc Lung Dis 2007; 11:289-92.
18. Fixsen DL, Naoom SF, Blasé KA, Friedman RM, Wallace F. Implementation research: a synthesis of the literature. Florida Mental Health Institute publication 231. Tampa: University of South Florida, The National Implementation Research Network, 2005.
19. Werner A. Introduction to implementation research [chapter 1]. In: A guide to implementation research. Washington, DC: Urban Institute Press. Available at: http://www.urban.org/pubs/implementationresearch/chapter1.html. Accessed 12 March 2007.
20. Habicht J-P, Victora CG, Vaughan JP. Evaluation designs for adequacy, plausibility and probability of public health programme performance and impact. Int J Epidemiol 1999; 28:10-8.
21. Macintyre S, Chalmers I, Horton R, Smith R. Using evidence to inform health policy: case study. BMJ 2001; 322:222-5.
22. Black N. Why we need observational studies to evaluate the effectiveness of health care. BMJ 1996; 312:1215-8.
23. Pronovost P, Wachter R. Proposed standards for quality improvement research and publication: one step forward and two steps back. Qual Saf Health Care 2006; 15:152-3.
24. Landon BE, Wilson IB, McInnes K, et al. Effects of a quality improvement collaborative on the outcome of care of patients with HIV infection: the EQHIV study. Ann Intern Med 2004; 140:887-96.
25. Wilson IB, Landon BE, Hirschhorn LR, et al. Quality of HIV care provided by nurse practitioners, physician assistants, and physicians. Ann Intern Med 2005; 143:729-36.
26. Hirschhorn LR, McInnes K, Landon BE, et al. Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics. Womens Health Issues 2006; 16:104-12.
27. Quality Assurance Project: assessing the economic impact of the new system of care for arterial hypertension in Tula Oblast, Russia. Available at: http://www.qaproject.org/pubs/PDFs/TulaAHCost.pdf. Accessed 2 March 2007.
28. Harley B. Integration of TB and HIV - programme level. Available at: http://www.columbia-icap.org/news/posters/ICAP2005/IntegrationTBHIVHarley.pdf. Accessed 2 February 2007.
29. Coetzee D, Hilderbrand K, Boulle A, Draper B, Abdullah F, Goemaere E. Effectiveness of the first district-wide programme for the prevention of mother-to-child transmission of HIV in South Africa. Bull World Health Organ 2005; 83:489-94.
30. Ferradini L, Segeral O, Nouhin J, et al. Efficacy of Kaletra-based second-line ART in Cambodia [abstract 36LB]. In: Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections (Los Angeles). Alexandria, VA: Foundation for Retrovirology and Human Health, 2007. Available at: http://www.retroconference.org/2007/Abstracts/30644.htm. Accessed 24 August 2007.
31. World Health Organization, Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report. April 2007.
32. Jackson DJ, Chopra M, Doherty TM, et al. Operational effectiveness and 36 week HIV-free survival in the South African programme to prevent mother-to-child transmission of HIV-1. AIDS 2007; 21:509-16.
33. Onyango C, Mmiro F, Bagenda D, et al. Early breastfeeding cessation among HIV-exposed negative infants and risk of serious gastroenteritis: findings from a perinatal prevention trial in Kampala, Uganda [abstract 775]. In: Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections (Los Angeles). Alexandria, VA: Foundation for Retrovirology and Human Health, 2007. Available at: http://www.retroconference.org/2007/Abstracts/29008. htm. Accessed 24 August 2007.
34. Creek T, Arvelo W, Kim A. A large outbreak of diarrhea among nonbreastfed children in Botswana, 2006 - implications for HIV prevention strategies and child health [abstract 9]. In: Program and abstracts of the 14th Conference on Retroviruses and Opportunistic Infections (Los Angeles). Alexandria, VA: Foundation for Retrovirology and Human Health, 2007. Available at: http://www.retroconference.org/2007/Abstracts/30582.htm. Accessed 24 August 2007.
35. Lockman S, Shapiro RL, Smeaton LM, et al. Response to antiretroviral therapy after a single, peripartum dose of nevirapine. N Engl J Med 2007; 356:135-47.
36. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomized controlled trial. Lancet 2007; 369:643-56.
37. Victoria CG, Habicht J, Bryce J. Evidence-based public health: moving beyond randomized trials. Am J Public Health 2004; 94:400-5.
38. O'Brien M, Xiong W, Hollingsworth E, et al. Resource requirements for HIV ART scale-up: a stochastic simulation model of a prototype HIV clinic for resource-constrained settings [abstract 545]. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections (Denver). Alexandria, VA: Foundation for Retrovirology and Human Health, 2005. http://www.retroconference.org/2006/Abstracts/27838.HTM. Accessed 24 August 2007.
39. Wilson DP, Blower SM. Designing equitable antiretroviral allocation strategies in resource-constrained countries. PLoS Med 2005; 2:e50.
40. Amirfar S, Hollenberg JP, Abdool Karim SS. Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa. J Acquir Immune Defic Syndr 2006; 43:219-25.
41. Xiong W, O'Brien M, Hollingsworth E, Rodriguez W, Hupert N. Planning HIV treatment clinic scale-up in resource-limited settings [abstract III:19]. In: Program and abstracts of the 28th Annual Meeting of the Society for Medical Decision Making (Boston). Philadelphia: Society for Medical Decision Making, 2006. Available at: http://smdm.confex.com/smdm/2006ma/techprogram/P3058. HTM. Accessed 24 August 2007.
42. Mshana GH, Wamoyi J, Busza J, et al. Barriers to accessing antiretroviral therapy in Kisesa, Tanzania: a qualitative study of early rural referrals to the national program. AIDS Patient Care STDS 2006; 20:649-5.
43. Population Council. Designing HIV/AIDS intervention studies: an operations research handbook. Available at: http://www.popcouncil.org/Horizons/ orhivaidshndbk.html. Accessed 21 April 2007.
44. Reerink IH, Sauerborn R. Quality of primary health care in developing countries: recent experiences and future directions. Int J Qual Health Care 1996; 8:131-8.
45. Ningsanond P, Fakthongkham K, Leusaree. Quality improvement (QI) of HIV/AIDS treatment and care in northern Thailand: a systematic approach [abstract THPE0952]. In: Program and abstracts of the 16th International AIDS Conference (Toronto). Geneva: International AIDS Society, 2006. Available at: http://www.iasociety.org/Default.aspx?pageIdp11&abstractIdp2196804. Accessed 24 August 2007.
46. Berwick DM. A learning world for the Global Fund. BMJ 2002; 325:55-6.
47. Marquez L, Madubuike C. Country experience in organizing for quality: Zambia. QA Brief 1999; 8:16-9.
48. McCarthy EA, O'Brien ME, Rodriguez WR. Training and HIV-treatment ART scale-up: establishing an implementation research agenda. PLoS Med 2006; 3:e304.
49. World Health Organization/Joint United Nations Program on HIV/AIDS. New data on male circumcision and HIV prevention: policy and programme implications, March 2007. Available at: http://data.unaids.org/pub/Report/2007/ mc_recommendations_en.pdf. Accessed 15 April 2007.
50. US Department of Veterans Affairs. QUERI program description. Available at: http://www1.va.gov/hsrd/queri/program.cfm. Accessed 3 March 2006.